Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03336216
Title A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

pancreatic adenocarcinoma

Therapies

Cabiralizumab + Gemcitabine + Nab-paclitaxel + Nivolumab

Cabiralizumab + Nivolumab

Fluorouracil + Irinotecan + Leucovorin

Gemcitabine + Nab-paclitaxel

Cabiralizumab + Fluorouracil + Irinotecan + Leucovorin + Nivolumab

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | CAN


No variant requirements are available.